Andres M. Ferreri

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications

Survival after first relapse in marginal zone lymphomas: Prospective data from the international observational NF10 study.

Survival after first relapse in marginal zone lymphomas: Prospective data from the international observational NF10 study.

Journal: British journal of haematology
Published: May 16, 2026

Increased risk of secondary malignancies after autologous transplantation in R/R follicular lymphoma: Long-term results from FIL-FLAZ12 Phase III trial.

Increased risk of secondary malignancies after autologous transplantation in R/R follicular lymphoma: Long-term results from FIL-FLAZ12 Phase III trial.

Journal: HemaSphere
Published: April 02, 2026

Decoding MRI Presentation of Primary Central Nervous System Diffuse Large B Cell Lymphoma: A Novel Subgroup Perspective.

Decoding MRI Presentation of Primary Central Nervous System Diffuse Large B Cell Lymphoma: A Novel Subgroup Perspective.

Journal: AJNR. American journal of neuroradiology
Published: November 11, 2025

Biomarkers for an early diagnosis of immune effector cell associated-hemophagocytic syndrome.

Biomarkers for an early diagnosis of immune effector cell associated-hemophagocytic syndrome.

Journal: Frontiers in immunology
Published: May 25, 2025

Six-month rituximab-lenalidomide regimen in advanced untreated follicular lymphoma: SAKK 35/10 trial 10-year update.

Six-month rituximab-lenalidomide regimen in advanced untreated follicular lymphoma: SAKK 35/10 trial 10-year update.

Journal: Blood advances
Published: September 17, 2024

Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease.

Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease.

Journal: Journal of neurology
Published: July 23, 2023

Primary central nervous system marginal zone lymphoma.

Primary central nervous system marginal zone lymphoma.

Journal: British journal of haematology
Published: July 20, 2023

Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study.

Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study.

Journal: Blood advances
Published: December 19, 2022

A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study.

A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study.

Journal: Blood advances
Published: July 06, 2021

Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial.

Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial.

Journal: Nature medicine
Published: July 02, 2021

CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL).

CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL).

Journal: Frontiers in oncology
Published: June 24, 2021

Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal type.

Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal type.

Journal: Current research in translational medicine
Published: June 01, 2021
Showing 1-12 of 61

Last Updated: 09/26/2026